Agentic AI Comes to Medicine
Agentic AI is moving into specialized medical functions through the acquisition of Grove AI by Hippocratic AI. Grove AI utilized voice agents to recruit patients for clinical trials. While tools like AI scribes are already in use by clinicians, the Federation of State Medical Boards argues that generative medical AI should not be licensed as individual practitioners. These developments occur as other sectors use agentic AI for market research, such as Simile creating AI twins for consumer surveys.
What changed
Hippocratic AI acquired Grove AI to integrate voice-based clinical trial recruitment agents.
Live updates
-
Hippocratic AI Acquires Grove AI as Medical Agentic Tech Expands
Agentic AI is moving into specialized medical functions through the acquisition of Grove AI by Hippocratic AI. Grove AI utilized voice agents to recruit patients for clinical trials. While tools like AI scribes are already in use by clinicians, the Federation of State Medical Boards argues that generative medical AI should not be licensed as individual practitioners. These developments occur as other sectors use agentic AI for market research, such as Simile creating AI twins for consumer surveys.
Why it matters
The shift toward agentic AI marks a transition from passive chatbots to systems that can execute complex tasks. This raises critical questions about professional licensing and the security of personal medical data. The industry is currently balancing rapid startup growth with regulatory caution.
What is confirmed
- Hippocratic AI acquired Grove AI earlier in 2026.
- Grove AI used voice agents to recruit eligible patients for clinical trials.
- Experts from the Federation of State Medical Boards state that generative medical AI should not be licensed as a separate practitioner like an individual clinician.
Still unconfirmed
- There is a lack of transparency regarding who has access to personal medical data handled by AI scribes.
- Simile has raised $200m at a $2bn valuation to build agentic twins for market research.
What to watch next
- Official licensing rulings from state medical boards regarding AI practitioners.
- Data privacy audits of AI scribe services.
- Integration results of Grove AI technology into Hippocratic AI platforms.
confidence 90%Sources used for this update (6)
- thenextweb.com — To find out what customers think, this $2bn startup asks their AI twins
- medcitynews.com — Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials
- www.statnews.com — We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine
- diginomica.com — Monday Morning Moan - stop it ERP/HR Vendors! You’re killing me with your bad AI pitches!!!
- www.swissinfo.ch — Oil Falls on Iran Deal Optimism, Yen Strengthens: Markets Wrap
- theconversation.com — Clinicians are using AI scribes, but what happens to your medical data?
-
Medical AI Integration Faces Licensing and Data Privacy Hurdles
Agentic AI is moving into clinical operations through recruitment and documentation, though regulatory and ethical concerns persist. Hippocratic AI recently acquired Grove AI, a startup that used voice agents for clinical trial recruitment. Meanwhile, medical experts argue against licensing generative AI as individual practitioners. Despite the adoption of AI scribes by clinicians, transparency remains low regarding how companies handle personal medical data. These developments show a shift from general chatbots to specialized agentic tools that interact directly with patients and clinical workflows.
Why it matters
The transition to agentic AI allows systems to perform autonomous tasks rather than just generating text. This shift creates tension between rapid commercial adoption and the slow pace of medical licensing and data privacy laws.
Still unconfirmed
- Grove AI was formed in 2024.
- Simile raised $200m at a $2bn valuation to create agentic twins for market research.
- Experts believe generative medical AI should not be licensed as a separate practitioner like an individual clinician.
What to watch next
- Official state medical board rulings on AI licensing.
- Legislative updates regarding the transparency of medical data handled by AI scribes.
confidence 90%Sources used for this update (6)
- thenextweb.com — To find out what customers think, this $2bn startup asks their AI twins
- medcitynews.com — Startup to Acquisition in 2 Years: Grove AI’s Journey to Transform Clinical Trials
- www.statnews.com — We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine
- diginomica.com — Monday Morning Moan - stop it ERP/HR Vendors! You’re killing me with your bad AI pitches!!!
- www.swissinfo.ch — Oil Falls on Iran Deal Optimism, Yen Strengthens: Markets Wrap
- theconversation.com — Clinicians are using AI scribes, but what happens to your medical data?
-
Agentic AI Enters Medicine, New Plans for Regulation
The application of agentic AI in medicine is advancing. Governments are reassessing regulations around AI development and deployment. The use of agentic AI is expanding beyond chatbots into various industries. New plans for AI regulation have been introduced.
What's confirmed:
- The Albanese government has reduced layers of regulation to support Australian innovation in AI.
- America faces a growing engineering shortage.
- Agentic AI could help manufacturers increase productivity and strengthen competitiveness.
Still unconfirmed:
- Agentic AI could bring work back home.
- The reduced regulation hands big tech too much power.
confidence 67%Sources used for this update (2)
-
Enterprise Shift Toward End-to-End Agentic AI Execution
Agentic AI is evolving beyond chatbots into software agents that handle business tasks across workflows and systems. Effective deployment requires specific infrastructure, including resilient data access and policy-aware tool use.
Still unconfirmed:
- Enterprise agentic AI consists of software agents that execute business tasks end-to-end across people, data, systems, and workflows.
- Ideal platforms for agents require memory management, observability, policy-aware tool use, resilient data access, and proper CPU capacity.
confidence 70%Sources used for this update (2)
-
Agentic AI Improves Sepsis Care and Healthcare Operations
Agentic AI is moving from research tools to clinical application. A recent study shows these agents can improve adherence to sepsis care protocols. The industry is shifting focus from model development to operational execution and practical utility.
What's confirmed:
- A cluster randomized trial of a Clairyon Inc. AI agent showed a 13% absolute improvement in compliance with sepsis care protocols.
- A study published in JAMA Network Open on June 25, 2026, validates the use of agentic AI in critical care.
Still unconfirmed:
- Chenyang Lu of the AI for Health Institute at Washington University in St. Louis is working to unite AI researchers and health professionals.
confidence 80%Sources used for this update (4)
-
Agentic AI Shifts Toward Biomedical Research and Discovery
AI systems are evolving into teams of computational experts that can perform literature reviews and formulate hypotheses. These agents target labor-intensive tasks in drug discovery and biomarker identification. NVIDIA has introduced a toolkit to support these scientific discovery agents.
What's confirmed:
- NVIDIA announced the BioNeMo Agent Toolkit to accelerate scientific discovery.
- Agentic AI systems can perform labor-intensive tasks such as data analysis, model interpretation, and hypothesis formulation.
Still unconfirmed:
- Drug discovery takes 15 years and costs $2.6 billion per treatment.
confidence 90%Sources used for this update (5)
- NVIDIA Announces BioNeMo Agent Toolkit — Tools for Agents to Accelerate Scientific Discovery
- Top 7 Agentic AI Use Cases in Healthcare (2025 Guide)
- Artificial Intelligence and Precision Medicine in Respiratory and Critical Care: From Data-Driven Diagnostics to Clinical Translation
- Agentic AI and the rise of in silico team science in biomedical ...
- Agentic AI Comes to Medicine - Live Feed
-
Agentic AI Emerges in Medical Practice
Medical AI is transitioning from predictive modeling to autonomous agents capable of executing clinical workflows. Recent developments include new models for emergency medicine and tools that match or exceed physician advice. While showing promise in diagnosis and planning, many systems still lack robust clinical validation.
What's confirmed:
- Agentic AI systems can operate autonomously to achieve specific clinical goals.
- Two new AI medical agent models for emergency medicine demonstrated superior adherence to clinical guidelines.
- AI medical tools have matched or surpassed doctors in providing advice.
- A scoping review of agentic AI identified applications in radiology, oncology, rehabilitation, and emergency medicine.
Still unconfirmed:
- AMIE could help manage health conditions.
confidence 90%Sources used for this update (16)
- Towards autonomous medical artificial intelligence agents
- Agentic AI Comes to Medicine
- AI medical tools match or surpass doctors for advice
- New research shows how AMIE, our medical AI, could help manage health conditions.
- OpenAI's health care threat is getting real
- Agentic AI Comes to Medicine - by Eric Topol
- Agentic AI Comes to Medicine - biztoc.com
- How Is Agentic AI Transforming Patient Care? | HealthPoint
- Nature Publishes Two New AI Medical Agent Models For Emergency ... - Digg
- Comments - Agentic AI Comes to Medicine - by Eric Topol
- Balancing innovation and implementation: Embracing agentic AI as a ...
- Post by @jonathanjarry.bsky.social — Bluesky